Followers | 15 |
Posts | 151 |
Boards Moderated | 0 |
Alias Born | 06/20/2020 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 03, 2021 11:34:29 AM
Dec 14, 2020 0.1450 0.1845 0.1331 0.1660 0.1660 11,687,101
Dec 11, 2020 0.1450 0.1450 0.1162 0.1205 0.1205 6,417,829
Dec 10, 2020 0.0900 0.1465 0.0809 0.1450 0.1450 19,609,741
Lobe Sciences Ltd. has launched a preclinical research study using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injury/concussion (“mTBI”) with post-traumatic stress disorder (“PTSD”).
The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami's Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.
https://www.lobesciences.com/technology
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM